Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study

Abstract Background and purpose We evaluated and compared the efficacy and safety of chemotherapy with paclitaxel plus cisplatin (TP) or carboplatin (TC) in patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC) who underwent neoadjuvant chemoradiotherapy (NCRT). Materials and m...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Li Jiang, Jie Zhu, Xue Chen, Yi Wang, Lei Wu, Gang Wan, Yongtao Han, Xuefeng Leng, Lin Peng, Qifeng Wang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2022-12-01
Rangatū:	Radiation Oncology
Ngā marau:	Neoadjuvant chemoradiotherapy Esophageal squamous cell carcinoma Locally advanced esophageal squamous cell carcinoma Carboplatin Cisplatin Paclitaxel
Urunga tuihono:	https://doi.org/10.1186/s13014-022-02190-4
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!